1-4 of 4
antigenic modulation
Close
Sort by
Journal Articles

Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies

Thomas R. W. Tipton, Ali Roghanian, Robert J. Oldham, Matthew J. Carter, Kerry L. Cox, C. Ian Mockridge, Ruth R. French, Lekh N. Dahal, Patrick J. Duriez, Philip G. Hargreaves, Mark S. Cragg, Stephen A. Beers
Journal: Blood
Blood (2015) 125 (12): 1901–1909.
https://doi.org/10.1182/blood-2014-07-588376
Published: 2015
Includes: Supplemental data
Journal Articles

Re-Evaluation of CD37 As Target for Radioimmunotherapy of Non-Hodgkin Lymphoma,

Jostein Dahle, PhD, Ada Repetto, Camilla Sivertsen Mollatt, Katrine Brustad Melhus, Øyvind Sverre Bruland, MD, PhD, Arne Kolstad, MD, PhD, Roy Hartvig Larsen, PhD
Journal: Blood
Blood (2011) 118 (21): 3732.
https://doi.org/10.1182/blood.V118.21.3732.3732
Published: 2011
Journal Articles

Weak Sensitivity of Myeloma Cells to CD38 or CD138-ADCC

Beatrice Clemenceau, PhD, Regine Vivien, Géraldine Descamps, Sophie Maiga, Martine Amiot, Henri Vié, Catherine Pellat-Deceunynck, PhD
Journal: Blood
Blood (2010) 116 (21): 4072.
https://doi.org/10.1182/blood.V116.21.4072.4072
Published: 2010
Journal Articles

Structural and Functional Consequences of Antigenic Modulation of Red Blood Cells With Methoxypoly(Ethylene Glycol)

Kari L. Murad, Kathleen L. Mahany, Carlo Brugnara, Frans A. Kuypers, John W. Eaton, Mark D. Scott
Journal: Blood
Blood (1999) 93 (6): 2121–2127.
https://doi.org/10.1182/blood.V93.6.2121.406a30_2121_2127
Published: 1999